| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/05/2011 | EP1567138B1 Use of a diamide derivative for inhibiting chronic transplant rejection |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | EP1463806B1 Novel cyclooxygenase variants and methods of use |
| 01/05/2011 | EP1401467B1 Alpha-fetoprotein peptides and uses thereof |
| 01/05/2011 | EP1301202B1 Genetically-engineered mhc molecules |
| 01/05/2011 | EP1294769B1 Antibodies that immunospecifically bind to blys |
| 01/05/2011 | EP1147214B1 A novel method for designing protein kinase inhibitors |
| 01/05/2011 | EP1128814B1 Aerosols comprising nanoparticle drugs |
| 01/05/2011 | CN1802388B CD20-specific antibodies and methods of employing same |
| 01/05/2011 | CN101939333A Non-aggregating human VH domains |
| 01/05/2011 | CN101939012A Macrolides for treating diseases mediated through PDE inhibition |
| 01/05/2011 | CN101935624A Bacillus subtillis and method for preparing raw powder of each gram of bacillus subtillis with 1 trillion live germs |
| 01/05/2011 | CN101935358A Ganoderma lucidum polysaccharide and preparation method thereof |
| 01/05/2011 | CN101935318A 2,3-dihydro-4(1H)- quinazolone derivative and application thereof |
| 01/05/2011 | CN101935315A Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 01/05/2011 | CN101934068A Preparation method of thymopetidum injection |
| 01/05/2011 | CN101934046A Semifluid extract of deer foetus and preparation method thereof |
| 01/05/2011 | CN101934044A Novel application of ginseng, tuckahoe and atractylodes preparation |
| 01/05/2011 | CN101933983A Traditional Chinese medicinal composition for treating allergic rhinitis, preparation thereof and preparation method thereof |
| 01/05/2011 | CN101933977A Traditional Chinese medicine composition against tooth sensitivity, toothpaste and preparation method thereof |
| 01/05/2011 | CN101933972A Nitric oxide reinforcing agent and application thereof |
| 01/05/2011 | CN101933953A Medicinal composition using zymoyic fungal powder of cordyceps sinensis, haematococcus pluvialis and honey as raw materials |
| 01/05/2011 | CN101933952A Medicinal composition with raw materials comprising fermented cordyceps mycelium powder, D-ribose and honey |
| 01/05/2011 | CN101933949A Application of traditional Chinese medicine medicated leaven in lysozyme-liposome coated with chitosan |
| 01/05/2011 | CN101933946A Preparation of bacillus subtilis preparation |
| 01/05/2011 | CN101933926A Indolylmaleimde derivatives as PKC inhibitors |
| 01/05/2011 | CN101933914A Desloratadine patch and preparation method thereof |
| 01/05/2011 | CN101933776A Anti-sensitive wet towel |
| 01/05/2011 | CN101491492B Full aloe gelatin |
| 01/05/2011 | CN101371891B Production method of composition of ginseng, astragalus and Ganoderma lucidum |
| 01/05/2011 | CN101313814B Health-care bedding and its making method |
| 01/05/2011 | CN101284040B Complex immunity strengthening agent for crabeater young fish |
| 01/04/2011 | US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders |
| 01/04/2011 | US7862828 Allergy vaccines containing hybrid polypeptides |
| 01/04/2011 | CA2627454C Hyaluronidase inhibitor containing poly-gamma-glutamic acid as an effective component |
| 01/04/2011 | CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 01/04/2011 | CA2491027C Novel flavone c-glycoside derivatives and compositions containing the derivatives |
| 01/04/2011 | CA2488363C O-substituted hydroxyaryl derivatives |
| 01/04/2011 | CA2479362C N-sulfonylurea apoptosis promoters |
| 01/04/2011 | CA2468517C Thioether substituted imidazoquinolines |
| 01/04/2011 | CA2460920C Stent coated with a sustained-release drug delivery and method for use thereof |
| 01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
| 01/04/2011 | CA2458533C Imidazole derivates as anti-inflammatory agents |
| 01/04/2011 | CA2451241C Unsymmetrical cyclic diamine compound |
| 01/04/2011 | CA2451238C Cyclic diamine compound with 5 membered ring groups |
| 01/04/2011 | CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives |
| 01/04/2011 | CA2413426C Methods and compositions utilizing quinazolinones |
| 01/04/2011 | CA2412941C Piperidine compounds for use as ccr-3 inhibitors |
| 01/04/2011 | CA2404128C Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/04/2011 | CA2389206C Activation of hcv-specific t cells |
| 01/04/2011 | CA2388301C Modified gp100 and uses thereof |
| 01/04/2011 | CA2384670C Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 01/04/2011 | CA2379909C Drug releasing biodegradable fiber implant |
| 01/04/2011 | CA2360692C Noninvasive vaccination through the skin |
| 01/04/2011 | CA2340174C Compositions of cpg and saponin adjuvants and methods thereof |
| 01/04/2011 | CA2333317C Stable oil-in-glycerin emulsion |
| 01/04/2011 | CA2301920C Vaccine |
| 01/04/2011 | CA2272046C Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/04/2011 | CA2129899C Dual carrier immunogenic construct |
| 01/04/2011 | CA2068654C Varicella-zoster virus antigen |
| 12/30/2010 | US20100331391 Zap-70 as predictor and modulator of effector function of t cells |
| 12/30/2010 | US20100331385 Pyrazole urea derivatives used as kinase inhibitors |
| 12/30/2010 | US20100331378 Aminotriazole derivatives as alx agonists |
| 12/30/2010 | US20100331372 Pyridin-2-yl derivatives as immunomodulating agents |
| 12/30/2010 | US20100331367 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 12/30/2010 | US20100331365 Piperidine derivative |
| 12/30/2010 | US20100331359 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 12/30/2010 | US20100331350 Inhibitors of bruton's tyrosine kinase |
| 12/30/2010 | US20100331342 Immuno Inhibitory Pyrazolone Compounds |
| 12/30/2010 | US20100331337 Quercetin-Containing Compositions |
| 12/30/2010 | US20100331319 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 12/30/2010 | US20100331315 Rhodanines and related heterocycles as kinase inhibitors |
| 12/30/2010 | US20100331314 Pyrazolopyrimidines and related heterocycles as kinase inhibitors |
| 12/30/2010 | US20100331306 Heterocyclic compounds and their uses |
| 12/30/2010 | US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides |
| 12/30/2010 | US20100331301 Azetidine compound and pharmaceutical use thereof |
| 12/30/2010 | US20100331298 Carboxamide Compounds and Their Use |
| 12/30/2010 | US20100331295 Modulators of lxr |
| 12/30/2010 | US20100331293 Heterocyclic compounds and their uses |
| 12/30/2010 | US20100331289 Combination of Azelastine and Steroids |
| 12/30/2010 | US20100331283 Mitotic kinesin inhibitors and methods of use thereof |
| 12/30/2010 | US20100331279 Inhibition of Antigen Presentation with Poorly Catabolized Polymers |
| 12/30/2010 | US20100331239 Cd14 and peptides thereof for protection of cells against cell death |
| 12/30/2010 | US20100331236 Cyclic peptides as g-protein coupled receptor antagonists |
| 12/30/2010 | US20100330673 Methods of making enhanced, autologous fat grafts |
| 12/30/2010 | US20100330613 Methods for determining efficacy of chemotherapeutic agents |
| 12/30/2010 | US20100330211 Fucoidan compositions and methods for dietary and nutritional supplements |
| 12/30/2010 | US20100330191 Diaminooxidase-containing pharmaceutical compositions |
| 12/30/2010 | US20100330183 Solid dispersing vaccine composition for oral delivery |
| 12/30/2010 | US20100330169 Pharmaceutical Tablet Containing A Liquid Filled Capsule |
| 12/30/2010 | US20100330163 Compositions and Methods for Enhancing Metal Ion Dependent Drug Therapies |
| 12/30/2010 | US20100330157 Biomaterial for the controlled delivery of ingredients |
| 12/30/2010 | US20100330156 Phenazine derivatives and uses thereof |
| 12/30/2010 | US20100330154 amphoteric liposomes comprising neutral lipids |
| 12/30/2010 | US20100330138 Biostable, multipurpose, microbicidal intravaginal devices |
| 12/30/2010 | US20100330128 Method of improving immune function in mammals using lactobacillus strains with certain lipids |
| 12/30/2010 | US20100330127 Soluble aggregate, immune tolerance inducer and manufacturing method thereof |
| 12/30/2010 | US20100330125 Novel polysaccharide immunogens from clostridium difficile |
| 12/30/2010 | US20100330124 Vaccine compositions and methods of use to protect against infectious disease |